Literature DB >> 2331984

Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen.

T Kobayashi1, S Nakamura, T Taniguchi, H Yamamura.   

Abstract

A cytosolic protein-tyrosine kinase has been highly purified from porcine spleen using [Val5]angiotensin II as a substrate. The purification procedure involves sequential column chromatographies on phosphocellulose, Sephacryl S-200, casein-Sepharose 4B, heparin-Sepharose CL-6B and anti-(4-aminobenzyl phosphonic acid)--Sepharose 4B. Analysis of the most highly purified preparation by SDS/PAGE revealed a major silver-stained band of molecular mass 40 kDa. The 40-kDa cytosolic protein-tyrosine kinase was purified approximately 10,000-fold with an overall yield of about 7%. It had autophosphorylation activity which was carried out by intramolecular catalysis. The stoichiometry of phosphate incorporation was about 1 mol phosphate/mol enzyme. In the autophosphorylation reaction, the apparent Km value for ATP was relatively low, 0.35 microM; Mn2+ was slightly preferred to Mg2+ as divalent cation. [Val5]Angiotensin II phosphorylation activity of the 40-kDa kinase increased with the amount of phosphate incorporated into the enzyme. A phosphate exchange reaction was observed during the autophosphorylation. These results suggest that the 40-kDa kinase described here is a different type of protein-tyrosine kinase than the enzymes so far reported.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331984     DOI: 10.1111/j.1432-1033.1990.tb15433.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  The role of Syk in peripheral T cells.

Authors:  Jeoung-Eun Park; Sirshendu Majumdar; David D Brand; Edward F Rosloniec; Ae-Kyung Yi; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  Clin Immunol       Date:  2018-04-16       Impact factor: 3.969

Review 2.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

3.  Purification of catalytic domain of rat spleen p72syk kinase and its phosphorylation and activation by protein kinase C.

Authors:  P Borowski; M Heiland; L Kornetzky; S Medem; R Laufs
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

4.  Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor.

Authors:  Beate Heizmann; Michael Reth; Simona Infantino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-12       Impact factor: 11.205

5.  3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.

Authors:  Vikas Kumar; Shraddha Parate; Amir Zeb; Pooja Singh; Gihwan Lee; Tae Sung Jung; Keun Woo Lee; Min Woo Ha
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

6.  Partial purification and characterization of the lck protein-tyrosine kinase from bovine thymus.

Authors:  Q M Wang; P R Srinivas; M L Harrison; R L Geahlen
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

7.  A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition.

Authors:  Andrew M Lipchik; Renee L Killins; Robert L Geahlen; Laurie L Parker
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

8.  Biochemical characteristics of cytosolic and particulate forms of protein tyrosine kinases from N-methyl-N-nitrosourea (MNU)-induced rat mammary carcinoma.

Authors:  A K Srivastava; J C Chiasson; J L Chiasson; A Lacroix; L Windisch
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

Review 9.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

Review 10.  Syk inhibitors in clinical development for hematological malignancies.

Authors:  Delong Liu; Aleksandra Mamorska-Dyga
Journal:  J Hematol Oncol       Date:  2017-07-28       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.